Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

109.29
Delayed Data
As of 4:00pm ET
 +1.13 / +1.04%
Today’s Change
64.03
Today|||52-Week Range
110.68
+21.06%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close108.16
Today’s open108.64
Day’s range108.11 - 109.66
Volume719,336
Average volume (3 months)637,994
Market cap$4.6B
Dividend yield--
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+32.81%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio128.6
Price/Sales12.92
Price/Book12.49

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+1.60+2.15%
NUVANuVasive Inc+0.45+0.76%
IARTIntegra LifeSciences...+1.78+2.28%
DXCMDexCom Inc+0.33+0.42%
Data as of 4:03pm ET, 06/30/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.23
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers

Search for Jobs